{"disease":{"id":"malignancy-hematologic","name":"malignancy hematologic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02958462","title":"Pre-myeloid Cancer and Bone Marrow Failure Clinic Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05713214","title":"Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT05819762","title":"Evaluation of ClearLLab LS Screening Panel","phase":"","overall_status":"COMPLETED","enrollment_count":831,"lead_sponsor_name":"Beckman Coulter, Inc.","has_results":false},{"nct_id":"NCT06487247","title":"HEME Home Transfusion Program","phase":"NA","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05270096","title":"International Leukemia Target Board","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Princess Maxima Center for Pediatric Oncology","has_results":false},{"nct_id":"NCT05882175","title":"Prospective Validation of the OHI Index","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT04720144","title":"Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT06904066","title":"Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00695279","title":"Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products","phase":"","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT05042479","title":"Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology.","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT05164016","title":"Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT03082677","title":"Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT04847050","title":"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04681105","title":"Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03878524","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false},{"nct_id":"NCT05205252","title":"A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Epizyme, Inc.","has_results":false},{"nct_id":"NCT05968170","title":"TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Neena Kapoor, M.D.","has_results":false},{"nct_id":"NCT07071909","title":"Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03739606","title":"Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"City of Hope Medical Center","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}